208 related articles for article (PubMed ID: 16265182)
1. How effective are rescue H. pylori eradication therapies in patients with dyspepsia?
Gisbert JP
Nat Clin Pract Gastroenterol Hepatol; 2005 Apr; 2(4):180-1. PubMed ID: 16265182
[No Abstract] [Full Text] [Related]
2. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C
Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori eradication in peptic dyspepsia.
Lule GN
East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
[No Abstract] [Full Text] [Related]
4. Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
Gisbert JP; Pajares JM
Helicobacter; 2005 Oct; 10(5):363-72. PubMed ID: 16181345
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial effectiveness of furazolidone against metronidazole-resistant strains of Helicobacter pylori.
Safaralizadeh R; Siavoshi F; Malekzadeh R; Akbari MR; Derakhshan MH; Sohrabi MR; Massarrat S
East Mediterr Health J; 2006; 12(3-4):286-93. PubMed ID: 17037696
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Helicobacter pylori infection.
Cavallaro LG; Egan B; O'Morain C; Di Mario F
Helicobacter; 2006 Oct; 11 Suppl 1():36-9. PubMed ID: 16925610
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
[TBL] [Abstract][Full Text] [Related]
8. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
9. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
Aliment Pharmacol Ther; 2006 Nov; 24(10):1469-74. PubMed ID: 17032282
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Helicobacter pylori.
Egan BJ; Katicic M; O'Connor HJ; O'Morain CA
Helicobacter; 2007 Oct; 12 Suppl 1():31-7. PubMed ID: 17727458
[TBL] [Abstract][Full Text] [Related]
11. Is there any effect of sequential eradication therapy of helicobacter pylori on functional dyspepsia symptom resolution?
Sarikaya M; Filik L; Doğan Z; Ergül B
Acta Gastroenterol Belg; 2013 Dec; 76(4):448-9. PubMed ID: 24592555
[No Abstract] [Full Text] [Related]
12. Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
Navarro-Jarabo JM; Fernández N; Sousa FL; Cabrera E; Castro M; Ramírez LM; Rivera R; Ubiña E; Vera F; Méndez I; Rivas-Ruiz F; Moreno JL; Perea-Milla E
BMC Gastroenterol; 2007 Jul; 7():31. PubMed ID: 17651479
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of dyspepsia in patients with functional dyspepsia, with the history of Helicobacter pylori eradication therapy in Cipto Mangunkusumo Hospital, Jakarta.
Utia K; Syam AF; Simadibrata M; Setiati S; Manan C
Acta Med Indones; 2010 Apr; 42(2):86-93. PubMed ID: 20513933
[TBL] [Abstract][Full Text] [Related]
15. Is nonulcer dyspepsia related to Helicobacter pylori infection?
Fennerty MB
Semin Gastrointest Dis; 2001 Jul; 12(3):180-5. PubMed ID: 11478750
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori eradication: role of individual therapy constituents and therapy duration.
Qasim A; O'Morain CA; O'Connor HJ
Fundam Clin Pharmacol; 2009 Feb; 23(1):43-52. PubMed ID: 19207543
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and non-malignant diseases.
Rokkas T; Simsek I; Ladas S
Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
[TBL] [Abstract][Full Text] [Related]
19. [Methods for increasing the efficacy and safety of Helicobacter pylori eradication regimens].
Zakharova NV
Eksp Klin Gastroenterol; 2006; (4):59-66. PubMed ID: 17269426
[No Abstract] [Full Text] [Related]
20. Current views on Helicobacter pylori eradication therapy.
Byrne MF; Murray FE
Ir Med J; 1998; 91(1):8-10. PubMed ID: 9563243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
